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I just ask you to hypothesize about the long-term results. Do you
think that this will be as successful long-term or will more patients
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Dr Samuel Money (Scottsdale, Ariz). I thank the authors for
sending me a copy of their manuscript well before this meeting.
The manuscript by Vallabhaneni and coauthors describes recana-
lizing chronic occlusions of the iliac system to facilitate placement
of devices for endovascular aneurysm repair (EVAR). It is quite an
interesting paper and quite an interesting concept. I have numer-
ous questions. My first question regards the actual incidence of this
occurring. You describe 14 patients at three very busy tertiary care
institutions over a 7-year period. How many total EVARs were
performed at these institutions, and how many were turned down?
You talk about 14 patients. Are we talking 1% of the total popula-
tion with abdominal aortic aneurysm (AAA) population, 2%, or
10%? It seems to me that this is a very, very small percentage of
patients; however, I would ask you to just sort of share with us what
percentage you really think this would be.
Another question: What was the mean size of your AAAs? You
describe a range from 3.1 to 7.6 with a mean of 5.1 cm. Clearly,
these are smaller aneurysms than one would expect; however, I
believe some patients were treated because of their occlusive dis-
ease. Can you please delineate on the fact that your average
aneurysm size was 5.1 cm?
You discuss one patient who had a ruptured external iliac. As
salvage for the bleeding you placed a covered stent. Did you then
have enough diameter to pass the endograft up with the Viabahn in
place? Or, did you place the endograft while there was still some
oozing and then place the Viabahn? My guess is you probably used
this as the contralateral limb, is this so?
My next question involves the use of additional bare-metal
stents. Did you use these? Frequently, when we place an endograft,
it lays in an area of unusual tortuosity or in an area of such severe
calcification that ballooning just does not help. We found that we
have probably reduced our iliac limb occlusions by placing a
self-expanding stent and sort of smoothing out the abrupt angu-
lation. I was wondering if you used any bare-metal stents in these
cases?
My final question complements you on this superb paper andeed what we call “touch-up procedures?” Thank you very much.
appreciate discussing this paper.
Dr Ehab E. Sorial. Thank you. In reference to the first
uestion, the actual incidence or the occurrence of this iliac occlu-
ion in the setting of aortic aneurysm is based on our institution,
he University of Kentucky. I would say we do approximately 70
VARs a year. It is hard to basically say how many of them had
ccluded iliacs. One of the flaws of the study is that we did not
dentify all patients who had iliac occlusions receiving open or
ndovascular repair. It was not a randomized trial. All that we
ooked at were patients who had iliac occlusions and aneurysms
ho underwent EVAR placement. So I would guess the range is
bout 2% to 5% to have the iliac occlusion and the aneurysm at the
ame time, but that is a guess.
In reference to the second question, most of these patients
nderwent EVAR placement for an aneurysm size5 cm. The few
atients that underwent aneurysm repair 5 cm are because of
laudication symptoms or because of their aneurysm being symp-
omatic.
The third question was regarding the iliac rupture that re-
uired placement of an external iliac Viabahn stent. The ruptured
liac in this patient happened after recanalizing his left side and after
lacement of main body of the aortic graft from the right side.
asically, trying to dilate the left external iliac with a bigger balloon
s when it ruptured. So the Viabahn stent was placed and extended
o the contralateral gate so at that time we already had the main
ody of the aortic graft placed from the contralateral side.
Regarding the use of bare-metal stents, we use them occasion-
lly for the distal part of the iliac limb at the tortuosity area just to
ack the graft down so that it does not begin “bird’s beaking” or
ust does not lift up, but in those patients, we used them just
ecause of the occlusive disease the patient had.
Successful long-term results? I speculate that possibly it will be
good option for a lot of patients, especially if we can recanalize
he iliacs. We have just a few years of follow-up on those patients,
ut I expect it is going to be a successful long-term outcome for
hese patients. Thank you.
